Clinical Trial Update: Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in very preterm infants has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)
• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: KK Women's and Children's Hospital | Conditions: Ductus Arteriosus, Patent, Very Low Birth Weight Infants | Phase 4 | Status: WITHDRAWN